Showing results (231-240 of 532) with videos related to
Sort By:
Pageof 54
The Journal of Clinical Investigation|October 25, 2016
Transcription factor ETV1 is essential for rapid conduction in the heartAkshay Shekhar, Xianming Lin, Fang-Yu Liu, et al.Plos One|May 19, 2011
Knowledge-driven multi-locus analysis reveals gene-gene interactions influencing HDL cholesterol level in two independent EMR-linked biobanksStephen D Turner, Richard L Berg, James G Linneman, et al.International Journal of Cardiology. Heart & Vasculature|June 6, 2022
Incidence rates of dilated cardiomyopathy in adult first-degree relatives versus matched controlsCharlotte Andersson, Morten Schou, Brian Schwartz, et al.Clinical Pharmacology and Therapeutics|March 30, 2019
Genome-Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for AllopurinolDeanna J Brackman, Sook Wah Yee, Osatohanmwen J Enogieru, et al.Journal of Personalized Medicine|March 28, 2024
Machine Learning Prediction of Treatment Response to Inhaled Corticosteroids in AsthmaMei-Sing Ong, Joanne E Sordillo, Amber Dahlin, et al.The Journal of Clinical Endocrinology and Metabolism|December 2, 2022
Association of Longitudinal Activity Measures and Diabetes Risk: An Analysis From the National Institutes of Health All of Us Research ProgramAndrew S Perry, Jeffrey S Annis, Hiral Master, et al.Journal of the American Heart Association|November 4, 2016
Contrasting Nav1.8 Activity in Scn10a-/- Ventricular Myocytes and the Intact HeartDina Myers Stroud, Tao Yang, Kevin Bersell, et al.Resuscitation|November 10, 2011
Hospital admissions and pharmacotherapy before out-of-hospital cardiac arrest according to agePeter Weeke, Fredrik Folke, Gunnar H Gislason, et al.Nutrition & Metabolism|October 16, 2009
Differential changes in serum uric acid concentrations in sibutramine promoted weight loss in diabetes: results from four weeks of the lead-in period of the SCOUT trialCharlotte Andersson, Peter Weeke, Bente Brendorp, et al.BMC Endocrine Disorders|February 27, 2010
The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in periodPeter Weeke, Charlotte Andersson, Emil L Fosbøl, et al.Pageof 54